Delivery Order SPE2DB20D1100-SPE2DB23FD6Z2
Award Date
9/19/23
Potential Completion Date
9/20/23
Potential Value
$2.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,155.77 delivery order contract is for the supply of Lantus 100 unit/ml vial (10 ml), a specialty medication used for the treatment of diabetes. The contract has an ultimate completion date of May 31, 2023 and is a firm fixed-price agreement. This award is part of a larger Indefinite Delivery Contract (IDC) held...
This federal contract award, valued at $1,200.70, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of LANTUS 100 UNIT/ML VIAL 10ML, a medication used to treat diabetes. The contract has a firm fixed price and an ultimate completion date of July 3, 2023. While the original solicitation is not provided, the award indicates that the contract is not...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,856.40 contract is a Firm Fixed Price Delivery Order for Lantus 100 Unit/ML Vial 10ML, a specialty medication used for treating diabetes. The contract has an ultimate completion date of November 20, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,533.68 firm fixed-price contract is for the supply of LANTUS 100 UNIT/ML VIAL 10ML, a specialty medication used in the treatment of diabetes. The contract has an ultimate completion date of June 27, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp is a Delivery Order valued at $1,008.09 for the supply of Lantus 100 unit/mL vial (10 mL). The contract has an ultimate completion date of September 17, 2024. It is a Firm Fixed Price contract with no set-aside designation, indicating open competition. AmerisourceBergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,491.10, is for the delivery of Lantus 100 unit/mL vial 10mL, a medication used to treat diabetes. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of August 5, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $2,159.44, is for the delivery of Lantus 100 unit/mL vials. This is a firm fixed-price delivery order contract with an ultimate completion date of August 24, 2021. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lantus 100 unit/mL vial, a prescription medication used to treat diabetes. The contract has a ceiling value of $3,875.82 and a completion date of September 15, 2023. It is a firm fixed-price contract, which means the price for the goods is set and not subject to adjustment. The...
This is a federal contract award made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,047.37, is for the delivery of LANTUS 100 UNIT/ML VIAL 10ML, a prescription medication used to treat diabetes. The award is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Lantus 100 unit/mL vial, 10mL, a medication used to treat diabetes. The contract has a ceiling value of $1,223.39 and runs through December 18, 2023. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open...